Survey to asses return to work and quality of life in lymphoma patients - a multicenter, prospective study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023970

Enrollment

100

Registered

2021-04-06

Start date

2021-05-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C81 C82 C83.1 C83.3

Interventions

Group 1: 1st assesment: start of systemic therapy 2nd and 3rd assesment: 6 and 12 months after end of treatment

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Hodgkin lymphoma, follicular lymphoma, diffuse large cell B-cell lymphoma, mantle cell lymphoma

Exclusion criteria

Exclusion criteria: no inclusion criteria, no consent to participate

Design outcomes

Primary

Measure	Time frame
- how many patients actualy return to work? In what time frame after completing therapy?	—

Secondary

Measure	Time frame
- how many patients, which have returned to work, stay at work? - how do patients themselves asses their prognosis in terms of returning to work?	—

Countries

Germany

Contacts

Public ContactRuth-Elisa Eyl

Stuttgart Cancer Center - Tumorzentrum Eva Mayr-Stihl

r.eyl@klinikum-stuttgart.de071127854951

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026